Safety, Tolerability, and Immunogenicity of Different Combinations of Trivalent Influenza Vaccine Varying Influenza Antigen Dose, Adjuvant Dose, and Route of Administration in Healthy Elderly Individuals Ages 65 Years and Older

NCT00848848 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

450

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza

Interventions

BIOLOGICAL: Trivalent Influenza Vaccine
BIOLOGICAL: Trivalent Influenza Vaccine + high A
BIOLOGICAL: Trivalent Influenza Vaccine + ¼ dose adjuvant
BIOLOGICAL: Trivalent Influenza Vaccine + high A + ¼ dose adjuvant
BIOLOGICAL: Trivalent Influenza Vaccine + ½ dose adjuvant
BIOLOGICAL: Trivalent Influenza Vaccine + high A + ½ dose adjuvant
BIOLOGICAL: Trivalent Influenza Vaccine + adjuvant
BIOLOGICAL: Trivalent Influenza Vaccine + high A + adjuvant
BIOLOGICAL: Trivalent Influenza Vaccine intradermal dose
BIOLOGICAL: Trivalent Influenza Vaccine + high A intradermal dose

Sponsor

Seqirus

Collaborators

[object Object]